samedi 17 octobre 2009
  5 Réponses
  10.5K Visites
Dear Friends, Here is more on intradermal delivery of vaccines. As many as 10 vaccines can be given intradermally to spare costs as well as doses, but unfortunately this is not promoted by vested interests. Please see the link on the WHO website: http://www.who.int/immunization_delivery/systems_policy/Intradermal-delivery-vaccines_report_2009-Sept.pdf Happy Diwali,Regards,Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology)Directorate of Health Safety and Regulation, Himachal Pradesh+91-9418120302[[email protected]][email protected][/email]; [email protected]
il y a environ 14 ans
·
#1610
Dear Darin, The efficacy of ID antirabies vaccine is not only proved beyond doubt but million of doses have been given including more than 24,000 doses in my clinic alone. I just wanted to draw the attention of the academia towards doing more efforts to find cheaper alternatives to costly vaccines to make them affordable including making vaccines available through ID route. Thanks and regards, Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology) Directorate of Health Safety and Regulation,Himachal Pradesh+91-9418120302 [[email protected]][email protected][/email]; [email protected]
il y a environ 14 ans
·
#1612
Thanks Dr. Nagraj, Actually in Thailand they are keeping the opened antirabies vaccine vials for a week at 4 degree celcius but nobody including WHO is promoting this method of preserving the vaccine, so we not only need new initiatives to bring down the costs of the vaccines but encourage those initiatives that promise so.When Thailand developed the intradermal technique of antirabies vaccination, it took around 13 years by WHO to recommend its use, I wish that this time period should be reduced to a minimum possible, in case new H1N1 vacines comes into picture to be given intradermally, so as to save costs, increase availability and save lives in the face of limited availability of the H1N1 vaccine. Harverson G, Post-exposure intradermal antirabies vaccine: a cheaper alternative for developing countries, Trop Doct. 1984 Apr;14(2):67-70. regards, Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology) Directorate of Health Safety and Regulation,Himachal Pradesh+91-9418120302 [[email protected]][email protected][/email]; [email protected]
  • Page :
  • 1
Il n'y a pas encore de réponse à ce message.